Evidence map›Paper›PMID 42210974›Full record

ArticleFrontiers in medicine2026

Development and validation of a MODS risk prediction model for organophosphorus poisoning patients.

Helong Yu, Ke Wang, Huisong Wu, Fangfang Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Helong YuDepartment of Emergency Medicine, Linquan County People's Hospital, Fuyang, Anhui, China.
Ke WangDepartment of Emergency Medicine, Linquan County People's Hospital, Fuyang, Anhui, China.
Huisong WuDepartment of Emergency Medicine, Linquan County People's Hospital, Fuyang, Anhui, China.
Fangfang LiDepartment of Emergency Medicine, Linquan County People's Hospital, Fuyang, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Multiple organ dysfunction syndrome (MODS) is a major complication of patients with acute organophosphorus pesticide poisoning (AOPP) and is associated with high mortality. This study aimed to develop and validate a MODS prediction model for this patient population using a nomogram and machine learning methods. Methods: A retrospective study was conducted on 270 AOPP patients from Linquan County People's Hospital to establish the prediction model. Lasso regression was used for variable selection, and multivariate Logistic regression was applied for model construction. Model performance was evaluated based on discriminative ability, calibration, and decision curve analysis. Results: Among the 270 AOPP patients, 129 (47.8%) developed MODS. The key predictors of MODS included heart rate, Endotracheal intubation, and blood lactic acid. The nomogram achieved an area under the curve (AUC) of 0.962 (95% confidence interval [CI]: 0.932-0.982). The calibration plot showed a high agreement between predicted probabilities and actual observed probabilities, and decision curve analysis demonstrated a favorable clinical net benefit of the model. Conclusion: We developed a risk prediction model for MODS in AOPP patients. This model can assist clinicians in assessing MODS risk and provide a scientific basis for subsequent interventions. External validation is required to confirm the reliability of the current risk model before its clinical application.

Indexed as

acute organophosphorus pesticide poisoningblood lactic acidendotracheal intubationheart ratemultiple organ dysfunction syndromenomogramprognosis

Identifiers

PMID42210974
PMCPMC13214578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.